Average Co-Inventor Count = 2.16
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Biomarin Pharmaceutical Inc. (21 from 135 patents)
2. Ultragenyx Pharmaceutical Inc. (17 from 27 patents)
3. Kyowa Kirin Co., Ltd. (4 from 45 patents)
4. Other (3 from 832,880 patents)
5. Harbor-ucla Research and Education Institute (2 from 11 patents)
6. Los Angeles Biomedical Research Institute at Harbor-ucla Medical Center (1 from 89 patents)
7. Merck Eprova Ag (1 from 6 patents)
44 patents:
1. 12358976 - Methods for increasing serum concentration of phosphorous and/or 1,25-hydroxy vitamin d
2. 11771748 - Methods for treating tumor-induced osteomalacia
3. 11753369 - Creatine prodrugs, compositions and methods of use thereof
4. 11505790 - Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof
5. 11332438 - Creatine prodrugs, compositions and methods of use thereof
6. 11202822 - Methods for treating hypophosphatemic disorders
7. 11040088 - Delivery of therapeutic compounds to the brain and other tissues
8. 10889607 - Sialic acid analogs
9. 10639360 - Methods for treating hypophosphatemic disorders
10. 10457701 - Sialic acid analogs
11. 10221408 - Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof
12. 10065981 - Sialic acid analogs
13. 9993481 - Methods and compositions for the treatment of metabolic disorders
14. 9937243 - Sialylated glycoprotein compositions and uses thereof
15. 9687532 - Sialylated glycoprotein compositons and uses thereof